See more : Thunder Bridge Capital Partners IV Inc. (THCPW) Income Statement Analysis – Financial Results
Complete financial analysis of Medcolcanna Organics Inc. (MCCN.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Medcolcanna Organics Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Tulasee Bio-Ethanol Limited (TULASEEBIOE.BO) Income Statement Analysis – Financial Results
- Petrolympic Ltd. (PCQRF) Income Statement Analysis – Financial Results
- Country Garden Holdings Company Limited (CTRYY) Income Statement Analysis – Financial Results
- Bactiguard Holding AB (publ) (0QV2.L) Income Statement Analysis – Financial Results
- Premier Explosives Limited (PREMEXPLN.NS) Income Statement Analysis – Financial Results
Medcolcanna Organics Inc. (MCCN.CN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://medcolcanna.com
About Medcolcanna Organics Inc.
Medcolcanna Organics Inc. operates as a medical cannabis company in Colombia and Switzerland. The company cultivates, produces, and distributes medicinal cannabis and cannabis derived products, including pharmaceutical, cosmetic, and bulk API products. Medcolcanna Organics Inc. is based in Calgary, Canada.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 95.77K | 1.58K | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 957.97K | 636.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | -862.19K | 946.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | -900.24% | 59.80% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 357.49K | 169.05K | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 4.42M | 5.76M | 130.34K | 130.87K |
| Selling & Marketing | 0.00 | 0.00 | 113.14K | 20.35K | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 4.53M | 5.78M | 130.34K | 130.87K |
| Other Expenses | 0.00 | 0.00 | 1.11M | 926.55K | 35.44K | 47.76K |
| Operating Expenses | 0.00 | 0.00 | 6.00M | 6.88M | 165.78K | 178.63K |
| Cost & Expenses | 0.00 | 0.00 | 6.96M | 6.88M | 165.78K | 178.63K |
| Interest Income | 0.00 | 0.00 | 2.76K | 20.79K | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 271.30K | 50.69K | 0.00 | 0.00 |
| Depreciation & Amortization | 228.49K | 236.56K | 166.02K | 179.88K | 4.07K | 5.43K |
| EBITDA | 0.00 | 0.00 | -6.96M | -6.96M | -164.14K | -175.62K |
| EBITDA Ratio | 0.00% | 0.00% | -6,998.68% | -423,598.74% | 0.00% | 0.00% |
| Operating Income | 0.00 | 0.00 | -6.87M | -6.88M | -165.78K | -178.63K |
| Operating Income Ratio | 0.00% | 0.00% | -7,172.02% | -434,969.41% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | -736.53K | -2.75M | -911.19K | -2.42K |
| Income Before Tax | 0.00 | 0.00 | -7.43M | -7.21M | -168.21K | -181.05K |
| Income Before Tax Ratio | 0.00% | 0.00% | -7,758.26% | -456,034.64% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | -69.40K | 50.69K | -2.43K | -2.42K |
| Net Income | 0.00 | 0.00 | -7.36M | -7.27M | -168.21K | -181.05K |
| Net Income Ratio | 0.00% | 0.00% | -7,685.80% | -459,238.75% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | -0.08 | -0.10 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | -0.08 | -0.10 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 95.42M | 71.54M | 85.65M | 85.65M |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 95.42M | 71.54M | 85.65M | 85.65M |
Source: https://incomestatements.info
Category: Stock Reports